header
Local cover image
Local cover image
Image from OpenLibrary

IL-21R polymorphism and response to treatment by interferon in Egyptian patients with chronic hepatitis C-CHC / Lamiaa Ahmed Fouad Ali ; Supervised Magda Ahmed Abdallah , Heba Mohamed Kamal , Amal Ahmed Mohamed

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Lamiaa Ahmed Fouad Ali , 2016Description: 131 P. : charts ; 25cmOther title:
  • التنوع الجينى لمستقبلات الانترلوكين 21 و الاستجابة للعلاج بالانترفيرون فى المرضى المصريين المصابين بالتهاب الكبد المزمن سى [Added title page title]
Subject(s): Online resources: Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (M.Sc.) - Cairo University - Faculty of Science - Department of Biochemistry Summary: HCV is a major cause of CHC. Egypt has the highest rate of HCV infection (genotype 4) in the world. IL-21R gene polymorphism is recently studied as pretreatment predictor in CHC patients treated with peg-INFplus ribavirin. In this study, we focus on evaluate of blood IL-21R gene polymorphism in CHC genotype 4 Egyptian patients and investigate it is benefit as a pretreatment predictor of antiviral response. This prospective study was carried out on 80 chronic hepatitis C (CHC) genotype 4 patients. All 80 CHC patients were subjected to treatment with pegylated Interferon alpha-2a (180 mcg subcutaneously once weekly for 48 weeks) plus ribavirin (1000-1200 mg/day according to body weight less or greater than 75 Kg) from January 2014 to January 2015. At the end of treatment our patients were divided into two groups; responders (44 patients) and non-responders (36 patients), all patients were subjected to different biochemical and IL-21R genotyping analyses. In conclusion, patients with IL-21R rs3093390 CC genotype had a higher sustained virological response to peg-INF treatment than those with non-CC genotypes
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.12.02.M.Sc.2016.La.I (Browse shelf(Opens below)) Not for loan 01010110072095000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.12.02.M.Sc.2016.La.I (Browse shelf(Opens below)) 72095.CD Not for loan 01020110072095000

Thesis (M.Sc.) - Cairo University - Faculty of Science - Department of Biochemistry

HCV is a major cause of CHC. Egypt has the highest rate of HCV infection (genotype 4) in the world. IL-21R gene polymorphism is recently studied as pretreatment predictor in CHC patients treated with peg-INFplus ribavirin. In this study, we focus on evaluate of blood IL-21R gene polymorphism in CHC genotype 4 Egyptian patients and investigate it is benefit as a pretreatment predictor of antiviral response. This prospective study was carried out on 80 chronic hepatitis C (CHC) genotype 4 patients. All 80 CHC patients were subjected to treatment with pegylated Interferon alpha-2a (180 mcg subcutaneously once weekly for 48 weeks) plus ribavirin (1000-1200 mg/day according to body weight less or greater than 75 Kg) from January 2014 to January 2015. At the end of treatment our patients were divided into two groups; responders (44 patients) and non-responders (36 patients), all patients were subjected to different biochemical and IL-21R genotyping analyses. In conclusion, patients with IL-21R rs3093390 CC genotype had a higher sustained virological response to peg-INF treatment than those with non-CC genotypes

Issued also as CD

There are no comments on this title.

to post a comment.

Click on an image to view it in the image viewer

Local cover image